Report - HEPATOCARCINOMA Dr. Daniel Raggio. 2 Estudios fase III demostraron aumento en sobrevida con sorafenib comparado con placebo. SHARP (n : 602 ) SV 10,7.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form